Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Fidelity Select Sector funds -- Ignore unavailable to you. Want to Upgrade?

To: rkf who wrote (2378)	3/6/2000 10:28:00 PM
From: seminole	Respond to of 4916

Kent I don't follow the fund manger at Dresdner. All the biotech fund are up smartly. IMO, the result are strongly correlated with this sector and not the fund managers picks. If I could pick any bio fund now it would be the one geared toward the small biotechs. IMO, we should see the returns on the larger bios slow down as the year continues. We should see an increase in takeover activity which will show the value others see in the sector. We should see more IPOs and secondary offerings throughout the year. If the IPOs do poorly, takeover activity stops, and the returns on large biotechs (like the core of FBIOX) go flat, get out. good luck richard